Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data
- 1 August 2013
- journal article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 13 (8), 690-697
- https://doi.org/10.1016/s1473-3099(13)70130-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factorsBulletin of the World Health Organization, 2012
- Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyThe Lancet, 2012
- Totally Drug-Resistant Tuberculosis in IndiaClinical Infectious Diseases, 2011
- Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010Bulletin of the World Health Organization, 2011
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateEuropean Respiratory Journal, 2011
- Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐AnalysisClinical Infectious Diseases, 2010
- Clonal Expansion of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, JapanEmerging Infectious Diseases, 2010
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli: Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in IranChest, 2009
- Scale-up of Multidrug-Resistant Tuberculosis Laboratory Services, PeruEmerging Infectious Diseases, 2008
- XDR Tuberculosis — Implications for Global Public HealthNew England Journal of Medicine, 2007